# Median Effective Dose of Remifentanil for the Prevention of Pain Caused by the Injection of Rocuronium

> **NCT05217238** · NA · UNKNOWN · sponsor: **Yangzhou University** · enrollment: 70 (estimated)

## Conditions studied

- Rocuronium
- Injection Pain

## Interventions

- **DRUG:** Remifentanil

## Key facts

- **NCT ID:** NCT05217238
- **Lead sponsor:** Yangzhou University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-18
- **Primary completion:** 2022-03-30
- **Final completion:** 2022-03-30
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2022-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05217238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05217238, "Median Effective Dose of Remifentanil for the Prevention of Pain Caused by the Injection of Rocuronium". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05217238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*